IiSGM has developed a novel and selective proteinbased radiotracer [99mTc]-DTPA-Collagen for the
selective detection of Gram-positive bacteria in
nuclear medicine (SPECT, PET, etc). This radiotracer
consist of the radioactive labelling of collagen type I.
The [99mTc]-DTPA-Collagen radiotracer is currently at TRL4, where an in vivo evaluation in two different animal models has been performed.
Intellectual property status
Patent already applied for
Patent application number : PCT/EP2021/062782
Where :
Desired business relationship
Technology selling
Patent licensing
New technology applications
The Institute is made up of the Servicio Madrileño de Salud (SERMAS), through the Gregorio Marañón University Hospital, which represents the basic nucleus of the Institute, and groups from the Primary Care area of the Hospital's area of influence, by the Complutense University of Madrid (UCM), the Carlos III University of Madrid (UCIII MADRID), the Foundation for biomedical research of the Hospital Gregorio Marañón (FIBHGM) and the General Directorate of Research, Training and Health Infrastructures of the Ministry of Health of the Community of Madrid.
Create your free account to connect with Daniel Sánchez Puerto and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Daniel
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
